Literature DB >> 13947924

The evaluation of imipramine in the treatment of Parkinson's disease.

R O GILLHESPY, D M MUSTARD.   

Abstract

Entities:  

Keywords:  IMIPRAMINE; PARALYSIS AGITANS; PARASYMPATHOLYTICS

Mesh：

Substances：

Year:  1963        PMID： 13947924

Source DB:  PubMed          Journal:  Br J Clin Pract        ISSN： 0007-0947


× No keyword cloud information.
  6 in total

1.  IMIPRAMINE IN TREATMENT OF PARKINSONISM: A DOUBLE-BLIND PLACEBO STUDY.

Authors:  R R STRANG
Journal:  Br Med J       Date:  1965-07-03

2.  Editorial: Miracle cures in Parkinson's disease.

Authors: 
Journal:  Br Med J       Date:  1975-07-05

Review 3.  Depression in Parkinson's disease. Pharmacological characteristics and treatment.

Authors:  T Tom; J L Cummings
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 4.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

5.  [The effects of desmethylimipramine (Pertofran) on catecholamine metabolism in the central nervous system and the Parkinson syndrome].

Authors:  N Matussek; H Pohlmeier
Journal:  Klin Wochenschr       Date:  1965-07-15

6.  Synergistic anticataleptic effect of imipramine and nicotine in a rotenone-induced rat model.

Authors:  Ilya D Ionov; Irina I Pushinskaya; Nicholas P Gorev; Larissa A Shpilevaya
Journal:  Psychopharmacology (Berl)       Date:  2019-05-08       Impact factor: 4.415
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.